We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

22 hedge funds and large institutions have $2.85M invested in Edesa Biotech in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

563% more capital inflows, than outflows

Capital inflows: $822K | Capital outflows: $124K

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

29% more funds holding

Funds holding: 17 → 22 (+5)

0.94% more ownership

Funds ownership: 1.97% → 2.91% (+0.94%)

Holders
22
Holders Change
+5
Holders Change %
+29.41%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Virtu Financial
Virtu Financial
New York
+$481K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$86.5K
3
State Street
State Street
Massachusetts
+$77.1K
4
Verition Fund Management
Verition Fund Management
Connecticut
+$75.1K
5
180 Wealth Advisors
180 Wealth Advisors
Washington
+$27.8K

Top Sellers

Rank Fund Capital Flow
1
Stifel Financial
Stifel Financial
Missouri
-$124K

EDSA Hedge Fund Activity: Q3 2021 in Review

22 of the 5,731 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q3 2021, worth a combined $2.85M — up 108% from $1.37M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new EDSA positions and 2 closed out — a net gain of 5 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, adding an estimated $481K. The largest seller was Stifel Financial, exiting entirely with an estimated $124K sold.

  • 22 institutional investors held Edesa Biotech (EDSA) as of Q3 2021, up from 17 in Q2 2021.
  • Funds reported $2.85M of Edesa Biotech stock for Q3 2021, up 108% quarter-over-quarter.
  • 7 funds opened new Edesa Biotech positions in Q3 2021 and 2 closed out, a net change of +5 holders.
  • The largest Edesa Biotech buyer in Q3 2021 was Virtu Financial, an estimated $481K added.
  • The largest Edesa Biotech seller in Q3 2021 was Stifel Financial, an estimated $124K sold.

Based on aggregated 13F filings for Q3 2021.